Literature DB >> 30995426

INCREASED MORTALITY IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM: DOES SURGERY MAKE A DIFFERENCE?

Andrew Collier, Sujoy Ghosh, Sian Nowell, David Clark.   

Abstract

Objective: Primary hyperparathyroidism (PHPT) is functionally characterized by an inappropriately raised secretion of parathyroid hormone, leading to raised serum calcium levels. Some patients are referred for parathyroidectomy, and some are managed conservatively. The aim of the audit was to compare the mortality outcomes between the two groups.
Methods: We retrospectively identified a cohort of inpatients with a main or secondary diagnosis of PHPT between 1986 and 2010 and followed them up to the end of 2011. The risk of mortality in PHPT patients compared to the background general population was estimated by calculating standardized mortality ratios (SMRs), adjusting for age, sex, and person-years at risk. Mortality in surgically treated patients was compared to conservatively treated patients using Cox regression, taking account of the Charlson Comorbidity Index.
Results: A total of 2,589 patients (77.9% females) were diagnosed with PHPT in Scotland over this period. Of patients diagnosed with PHPT, 41.6% (1,077/2,589) had died by the end of 2011. The SMR was 1.58 (95% confidence interval [CI], 1.48 to 1.67). A total of 54.8% of the patients underwent surgery (SMR, 1.30; 95% CI, 1.18 to 1.43), while the rest were treated "conservatively" (SMR, 1.88; 95% CI, 1.73 to 2.03) (P<.001). When other significant variables including the Charlson Comorbidity Index were taken into account in the final model, the hazard ratio for the "conservatively" managed group was reduced to 1.49 (95% CI, 1.30 to 1.70; P<.0001).
Conclusion: Our study confirmed that inpatients diagnosed with PHPT have increased mortality. The risk of mortality was lower in those treated surgically compared with patients treated conservatively. Abbreviations: CI = confidence interval; HR = hazard ratio; PHPT = primary hyperparathyroidism; PTX = parathyroidectomy; SMR = standard mortality ratio; SMR01 = Scottish Morbidity Records.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30995426     DOI: 10.4158/EP-2018-0407

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  2 in total

Review 1.  Preoperative Localization for Primary Hyperparathyroidism: A Clinical Review.

Authors:  Donovan Tay; Jeeban P Das; Randy Yeh
Journal:  Biomedicines       Date:  2021-04-06

2.  18F-choline PET/CT and PET/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature.

Authors:  Laura Evangelista; Ilaria Ravelli; Fabio Magnani; Maurizio Iacobone; Chiara Giraudo; Valentina Camozzi; Alessandro Spimpolo; Diego Cecchin
Journal:  Ann Nucl Med       Date:  2020-08-07       Impact factor: 2.668

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.